Understanding the Clinical Features of Fronto-Temporal Dementia (FTD) Fronto-Temporal Dementia (FTD) is a group of brain disorders characterized by the progressive loss of neurons in the frontal lobes and/or temporal lobes of the brain. These areas are associated with personality, behavior, and language. Let's examine the provided statements to identify the clinical features of FTD.

Analyzing Fronto-Temporal Dementia Features

We will look at each statement presented in the question:

• Statement I: Personality change
  • This is a hallmark feature of FTD, particularly the behavioral variant (bvFTD).
  • Patients often exhibit significant alterations in personality and behavior.
  • Common changes include apathy (loss of interest), disinhibition (acting impulsively or inappropriately), emotional blunting, loss of empathy, and repetitive or compulsive behaviors.
  • Therefore, personality change is a key clinical feature of FTD.
• Statement II: Language disturbance
  • Language problems are prominent in other common variants of FTD, such as Primary Progressive Aphasia (PPA).
  • PPA itself has subtypes involving difficulties with speaking (non-fluent PPA), word finding and sentence comprehension (semantic dementia), or a combination.
  • So, language disturbance is also a significant clinical feature associated with FTD.
• Statement III: Memory may be preserved in early stages
  • This statement accurately describes a key difference between FTD and Alzheimer's disease.
  • While Alzheimer's disease typically presents with prominent early memory loss, FTD often shows relatively preserved memory function in the initial stages.
  • The primary symptoms are usually behavioral or language-related.
  • Hence, memory preservation in the early phase is a characteristic of FTD.
• Statement IV: Anti-cholinesterases are the drug of choice for treatment
  • This statement is incorrect.
  • Anti-cholinesterase inhibitors (like donepezil, rivastigmine, galantamine) are commonly used to manage symptoms in Alzheimer's disease by increasing acetylcholine levels in the brain.
  • However, they are generally found to be ineffective for the core symptoms of FTD and are not considered the treatment of choice.
  • There is currently no cure for FTD, and treatment focuses on managing symptoms with medications (like antidepressants for behavioral issues) and non-pharmacological approaches (supportive care, speech therapy, occupational therapy).

Conclusion on FTD Features

Based on the analysis:

• Statement I (Personality change) is a clinical feature of FTD.
• Statement II (Language disturbance) is a clinical feature of FTD.
• Statement III (Memory may be preserved in early stages) is a clinical feature of FTD.
• Statement IV (Anti-cholinesterases are the drug of choice) is incorrect regarding treatment.

Therefore, the correct clinical features are represented by statements I, II, and III. The option that includes these three statements is the correct answer.